Novel Natural Antibody Therapeutics (IMAGE)

U.S. National Science Foundation

Novel Natural Antibody Therapeutics

Caption

NSF spurs the translation of fundamental research into innovation through investment in high-tech small businesses and in broad-based, regional collaborations between academia and industry. Shown here is an image from GigaGen Inc., an NSF-funded small business that is creating novel natural antibody therapeutics. GigaGen is one of nearly 40 NSF grantees participating in the 2015 BIO Innovation Zone, an exhibit space dedicated to businesses with cutting-edge biomedical technologies supported by NSF's Directorate for Engineering.

Credit

GigaGen Inc.

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.